- Open Access
An overview of control strategy and diagnostic technology for foot-and-mouth disease in China
© Ding et al; licensee BioMed Central Ltd. 2013
- Received: 25 April 2012
- Accepted: 26 February 2013
- Published: 7 March 2013
Foot-and-mouth disease (FMD) is one of most contagious animal diseases. It affects millions of cloven-hoofed animals and causes huge economic losses in many countries of the world. There are seven serotypes of which three (O, A and Asia 1) are endemic in China. Efficient control of FMD in China is crucial for the prevention and control of FMD in Asia and throughout the world. For the control of FMD, a powerful veterinary administration, a well-trained veterinary staff, a system of rapid and accurate diagnostic procedures and, in many countries, compulsory vaccination of susceptible animals are indispensable. This article strives to outline the Chinese animal disease control and prevention system, in particular for FMD, with the emphasis on diagnostic procedures applied in Chinese laboratories. In addition, new technologies for FMD diagnosis, which are currently in the phase of development or in the process of validation in Chinese laboratories, are described, such as lateral flow devices (LFD), Mab-based ELISAs, reverse transcription loop-mediated isothermal amplification (RT-LAMP) and gold nanopariticle immuno-PCR (GNP-IPCR).
- Foot-and-mouth disease
- Control strategy
- Chinese veterinary administrative system for FMD
- Diagnostic technique
Foot-and-mouth disease (FMD) is one of the most contagious diseases of mammals which has caused severe economic losses for production of susceptible cloven-hoofed animals. There are seven serotypes of FMD virus (FMDV), namely, O, A, C, SAT 1, SAT 2, SAT 3 and Asia 1. The genome of the virus is over 8 kb in length and encodes four structural proteins (SPs, VP1, VP2, VP3 and VP4) that form an icosahedral capsid , and a total of ten mature non-structural proteins (NSPs) (L, 2A, 2B, 2C, 3A, 3B, 3C, 3D, 3AB or 3ABC).
This disease has been controlled successfully in many countries with the strategies such as mandatory vaccination of susceptible animals and slaughtering of infected animals. However, no country has been considered safe due to the highly contagious nature of the virus and the intensified international trade of animal or animal products . FMD serotypes O, Asia 1 and A have been endemic in different regions in China since 1999. To control the spread of the disease and to eradicate the virus, many measures have been taken by the Chinese government including compulsory immunisation, an animal disease reporting system, the development of rapid diagnostic techniques and the generation of a new vaccine.
In this article, we introduced the FMD control and prevention system in China, routine diagnostic methods in OIE/China National Foot-and-Mouth Disease Reference Laboratory and some new methods, which are still not validated for FMD diagnosis, such as LFD, IPCR and LAMP.
FMD control and prevention system
The Standing Committee of the National People’s Congress or veterinary administrative department of Ministry of Agriculture in China proclaimed several laws for the purpose of FMD control such as the Animal Epidemic Prevention Law of the People’s Republic of China, The Quarantine Law of the People’s Republic of China on the Import and Export Animal and Plant, Emergency Measures for Handling Major Animal Epidemics and Contingency plans of Prevention and control of Foot-and-mouth Disease.
The organization for FMD control and prevention consists of four levels of veterinary administrative departments ranging from central, provincial, and municipal to the county government, an OIE/China National Foot-and-mouth Disease reference laboratory, animal disease monitoring stations and border animal epidemic monitoring stations.
Foot and mouth disease reporting procedures
Foot and Mouth Disease suspected case report procedure: The suspected case was first confirmed when one of the clinical signs or syndromes of foot-and-mouth disease appears on susceptible animals in accordance with epidemiology characteristics of FMD. According to the law, the veterinarians or farmers should promptly report the FMD suspected case to the local Animal Disease Control and Prevention Center (ADC). At least 2 official veterinarians in the ADC of that county should immediately go to the holdings to check and collect samples of the suspected FMD case and subsequently take control measures after receiving the report. The confirmed suspected FMD cases should be reported to the local veterinary bureau and the higher administrative authority. The samples of FMD suspected cases should be collected and sent to the provincial animal disease control center, or to the national foot-and-mouth disease reference laboratory, if necessary. The official veterinarian should take necessary control measures for FMD suspected cases, including separation and monitoring of the suspected FMD case, movement restriction of animal or animal products, and disinfection of the holding and the environment before the laboratory diagnostic result was obtained.
Confirmed FMD report procedure: The outbreak of FMD can be confirmed if the result for one of the FMDV causative agent assays in laboratory diagnosis was positive or 3ABC nonstructural protein was positive for the FMD suspect case. The provincial ADC should report the FMD case within 1 hour to the provincial veterinary administrative department and Center for Animal Disease Control and Prevention (CADC) of the People’s Republic of China. The provincial veterinary administrative department should report the FMD confirmed case to the government of the province and the national veterinary administrative department within 1 hour.
OIE/China National Foot-and-mouth Disease Reference Laboratory should report the diagnostic result to national CADC and the veterinary competent authority of the state council of China, and notify, at the same time, the provincial veterinary administrative department, as well as the provincial CADC, of the outbreak of FMD.
The veterinary competent authority of the state council of China is responsible for declaring the confirmed FMD outbreak to the OIE base on the laboratory diagnostic results conducted by the provincial animal disease control center or the national foot-and-mouth reference laboratory and making sure that the necessary control measures to eradicate an FMD epidemic are taken as soon as possible.
The main FMD control measures in China
In China, a compulsory vaccination strategy for FMD is applied. The costs of vaccination are jointly funded by the central and provincial governments. Inactivated or peptide vaccines for FMDV are produced by different manufacturers which all have to be licensed by the Ministry of Agriculture. The quality of FMD vaccines are controlled by the Chinese Institute for the Control of Veterinary Drugs. The annual compulsory vaccination plan is approved by the Ministry of Agriculture. In recent years, a compulsory vaccination scheme has been followed which includes immunization of all pigs against serotype O (with inactivated or peptide vaccines) and all cattle, sheep, goat, deer and camel against serotypes O and Asia 1 (with inactivated vaccines), while all dairy cows and bulls as well as susceptible animals in border areas are also immunized against serotype A (with inactivated vaccines). The interval of FMDV vaccine immunization is no more than six months. The regular serological survey should ensure that the qualified rate of titer of FMDV antibody in the herd reached more than 70%. It is necessary to prevent any spread of the disease as soon as an outbreak occurs by monitoring livestock movements and emergency booster vaccination. When an FMD outbreak is confirmed, the control measures are as follows.
Firstly, infected and contaminated susceptible animals should be slaughtered without delay. Animal bodies and suspected contaminated feces, litter, feed and sewage should be disinfected under official supervision in accordance with the instructions provided by the official veterinarian. Then, the strict disinfection of contaminated traffic vehicles, animal houses and relevant tools should be conducted. Thirdly, the local ADC should trace animals dispatched from the infected zones during the period of at least 21 days before the estimated date of earliest infection to monitor the spread of disease. Next, the veterinary administrative departments delimit the warning signs around the epidemic area (EA) of FMDV, and build up disinfection stations in the EA to carry out disinfection and control measures. Subsequently, the local ADC should carry out epidemiological investigation, monitoring and risk evaluation of susceptible animals in EA. Veterinarian should urgently carry out booster immunization for susceptible animals using inactivated vaccines. Last but not least, the trade markets of susceptible animals in the EA should be closed.
To relieve the FMD alert: the provincial ADC and OIE/China National Foot-and-Mouth Disease Reference Laboratory are responsible for FMD surveillance since the infection occurred. If no new cases of infected animals occur within 14 days of the slaughter of the last infected animal in the EA, the local veterinary bureau should apply to the local government to announce the relieving of the FMD alert in the EA. The animal or animal product circulation should resume from the EA three months after the FMD alert was lifted.
The Chinese government has conducted a long-term plan for FMD control and prevention. The objective of the plan is to achieve FMD serotype Asia 1 and serotype A free status in the whole China region without vaccination by 2020.
Routine laboratory diagnostic techniques for FMDV
Isolation of FMDV viruses
As requested by OIE/China National Foot-and-Mouth Disease Reference Laboratory, a sample of at least 1 g of epithelial tissue (from the tongue, buccal mucosa or feet), homogenized in a transport medium composed of 5 times the amount of 0.04 M phosphate buffer (pH 7.2–7.6) and incubated overnight at 4°C should be sent to the laboratory. This FMDV suspect fluid is then centrifuged at 10,000 rpm for 10 min and 0.2 ml of this supernatant is injected into 10 2–5 day old unweaned mice to grow the virus. Some field viruses may require several passages before they become adapted to mice . Meanwhile, the field suspected FMDV samples are also inoculated onto bovine thyroid cell or BHK-21 (baby hamster kidney) cell cultures for 48 hours to look for cytopathic effect (CPE). If no CPE is detected, the cells should be frozen and thawed and used to inoculate fresh cultures for the examination of CPE after another 48 hours . Virus isolation in cell culture is considered to be the “gold standard” however, it may take up to four days to confirm which will delay the initiation of control procedures.
ELISA for FMDV diagnosis/typing
Virus isolation in primary cultures requires days/weeks (cell passages) before the results are obtained . In general, the ELISA using type-specific serological reagents is the preferred procedure for the detection of FMD viral antigen and identification of viral serotype in the early stages of research because it is more specific, sensitive and efficient than virus isolation [6–8]. Different ELISA formats, particularly indirect ELISA, involved in blocking- or competition- or sandwich-based assays have been playing an increasing important role in the detection of FMDV or serological surveillance .
So far, over the past several decades, a series of ELISA methods have been developed in China for the diagnosis of FMD. These methods are theoretically consistent with Office International des Epizooties standards for FMD diagnosis and include antigen-capture ELISA for FMDV viral antigen typing, liquid-phase blocking ELISA (LPBE) for detection of antibodies against O, A and Asia 1 FMDV, and an indirect ELISA for detection of antibodies against the non-structural protein (NSP) 3ABC (3ABC-I-ELISA), which have been developed into diagnostic kits for FMDV diagnosis, serological surveillance and differentiation of FMD from swine vesicular disease viruses(SVD) .
LPBE for detection of antibodies against FMDV serotype A have been applied practically in 2010. This method replaces indirect haemagglutination and is a widely used assay for immune status surveys. The correlation between LPBE titer and challenge protection rate of animals immunized with FMD vaccine was established by challenging vaccinated animals with high virulent FMD virus .
The 3ABC ELISA (3ABC-I-ELISA) has been developed into a diagnostic kit for FMDV at the OIE/China National Foot-and-mouth Disease Reference Laboratory and applied in the field to differentiate between FMDV infection and vaccination. This can be used as a reliable tool for massive serological surveys to estimate the level of subclinical virus infection and to detect early incursion of FMDV into an animal population, regardless of viral serotype involved. These tests are especially important in the vaccination scenario due to its effectiveness on large-scale farm evaluation . The shortcoming of the method is false-positive results for the sera of boars or bulls, which are subjected to multiple immunizations with inactivated vaccine .
RT-PCR and multiplex RT-PCR or real-time PCR
Compared to the virus isolation and antigen-capture ELISA, reverse transcription PCR (RT-PCR) has the advantage of greater sensitivity, reproducibility, reduced risk of carry-over contamination, and the results can be obtained in about 2 to 4 hours. RT-PCR can also be used to amplify genome fragments of FMDV of diagnostic materials including epithelium, milk, serum and OP samples. OIE/China National Foot-and-mouth Disease Reference Laboratory provides two RT-PCR kits for FMDV diagnosis, including general RT-PCR and a multiplex RT-PCR (mRT-PCR) kit. The real-time RT–PCR kit was designed to detect a 91 base pair nucleotide fragment within the 3D coding region. This method is sensitive enough to detect 0.1 TCID50 of FMDV from cell culture samples .
In OIE/China National Foot-and-mouth Disease Reference Laboratory, the multiplex RT-PCR is the preferred technology for investigation of FMDV. Three different fragments are amplified in this multiplex RT-PCR, 634 bp, 483 bp and 278 bp, representing FMDV serotypes A, Asia 1 and O samples, respectively. In the assay, three primer sets were used in a multiplex RT-PCR for rapid detection of virus in tissue samples or OP fluids of carriers of FMD. By testing ten-fold serial dilutions of FMDV, the sensitivity of multiplex RT-PCR is higher than that of conventional RT-PCR. This method has the potential to detect the prevalence of FMDV, and differentiate between other related viruses (BVDV, SVDV, VSV, VESV) .
New detection methods
The characterization and limitation of new diagnostic methods including lateral flow device, the new ELISA assay, RT-LAMP and immuno-PCR assays for FMDV were reviewed, respectively. The lateral flow device has been validated and the other assays were being developed or in the process of validation in China.
Lateral flow device (LFD)
Ferris et al., developed a lateral flow device (LFD) for the detection of FMDV using different FMDV Mab . The sensitivity and specificity of the LFD for FMDV was compared to ELISA. The results indicated that the sensitivity for the detection of FMDV serotype SAT2 was enhanced from 65% to 90% when the monoclonal antibody (Mab) 1 F10 in the devices was substituted with the Mab 2H6. The specificity of the LFD (99.4%) is comparable and the sensitivity (88.2%) for the detection of FMDV type SAT 2 antigen is superior to that of the slower and more complicated antigen ELISA (100% and 79%). The sensitivity and specificity of the LFD assay relies on the recognition of the Mab to the conservative antigenic epitope of FMDV. Compared to ELISA, the LFD procedure is very simple, rapid, and easy to perform and the results can be read by the naked eye. The LFD has the potential to be used in the pen-side diagnosis and serotyping of FMD [13, 14]. The official veterinarian can start to implement measures according to the result of LFD as preliminary proof of an outbreak.
New ELISA assay
A serotype-specific Mab-based antigen detection ELISA developed at the Istituto Zooprofilatico Sperimentale, Brescia, Italy, relies on a mixture of at least 3 different Mabs against each of the serotypes O, A and C to detect FMD virus in clinical samples .
As the monoclonal antibodies (Mabs) of FMDV define a specific region, a large number of viruses can be analyzed against a panel of Mab in a single test . In our laboratory, we obtained the MAbs of FMDV with the exact epitope that covers the region from amino acid 133 to 160 of VP1 of FMDV Serotype O (CHA/1999). We developed the Mab based antigen capture ELISA for the detection of FMDV type O, which could discriminate between serotype A, C, Asia-1 and SVDV, so the development of synthetic technologies for conformational peptides would have great potential for preparation of monoclonal antibodies against conformational epitopes . The MAbs with the exact epitopes could also be used to develop the assays for the specific FMDV field viruses.
Conventional laboratory diagnosis of FMD is conducted with ELISA detection of specific viral antigens and by observation of cytopathic effects in cell culture . Alternatively, the conventional reverse transcriptase polymerase chain reaction (RT-PCR)  and real-time RT-PCR  were used to complement primary diagnosis of the FMDV infection. These assays were laborious and required relatively expensive laboratory facilities. To solve these problems, a rapid, simple and practical assay, designated reverse transcription loop-mediated isothermal amplification (RT-LAMP), was developed to detect FMDV in animal and its products.
To assess the specificity of RT-LAMP, cross reactivity with RNA from CSFV, SVDV, PRRSV and JEV was examined. The results indicated that the FMDV RT-LAMP assay did not detect CSFV, SVDV, PRRSV and JEV, as well as gave a negative reaction with tissues of healthy swine. FMDV RNA gave a positive reaction .
RT-LAMP is a sensitive diagnostic method, which is quite simple, requiring only a conventional water bath or heat block for incubation under isothermal conditions [22–24]. Another useful feature of RT-LAMP is that its products can be observed directly by the naked eye, because a white precipitate of magnesium pyrophosphate forms in the reaction tube . The RT-LAMP assay is a timesaving procedure, as well, since the results can be obtained within 1 hour, whereas RT-PCR method typically requires 2 to 4 hours. The success of the LAMP assay depends on the high match between the four or six primers with the target sequence of FMDV. The characteristics of quasi-species of FMDV may reduce the sensitivity of the RT-LAMP assay, therefore it is necessary to evaluate the sensitivity of the assay using a large quantity of field samples of FMDV before practical application. Furthermore, the RT-LAMP assay has the potential for pen-side diagnosis as a rapid diagnostic assay, if it can be developed to work directly with clinical samples include epithelial tissue, OP fluid etc., rather than extracted RNA. The sensitivity and specificity of pen-side FMDV RT-LAMP should be evaluated in the future.
Recently, a new highly sensitive assay, namely a bio-barcode amplification (BCA) assay, was developed for ultrasensitive detection of target proteins and nucleic acids, with the detection limit reaching the level of 30 attomolar (aM) . This method has been applied successfully to the detection of many animal viruses [29–31] and offers an excellent analytical sensitivity compared ELISA and conventional PCR. Based on the principles of the bio-barcode assay, a highly sensitive gold nanopariticle (GNP) improved immuno-PCR (GNP-IPCR) assay for the detection of FMDV antigen was designed. The target viral particles were captured by polyclonal or monoclonal antibodies coated to ELISA microplates, followed by incubation with GNP, which had been dually modified with oligonucleotides and a FMDV specific monoclonal antibody. After the formation of an immune complex and several washing steps, the signal DNA was released by heating and assayed by PCR.
Although this method combining the applicability of detection of antigen from ELISA and the high sensitivity of PCR which offers an excellent analytical sensitivity due to very high signal amplification, the specificity was easily affected if the washing step was not performed thououghly. Nevertheless, GNP-IPCR is still an improved assay compared with immuno-PCR.
Foot-and-mouth disease virus (FMDV) is a severe pathogen which can cause widespread epidemics. Early detection of FMD is essential for effective control of the disease. A simple, rapid, noninvasive diagnostic test is critical for FMD diagnosis. Although many diagnostic assays or kits are available to date for the control of FMDV, many works including an efficient veterinary disease prevention system, rapid diagnostic tests and an efficacious vaccine are still urgently needed with regard to FMD eradication.
This work was supported in parts by grants International Science & Technology Cooperation Program of China (No. 2010DFA32640 and No. 2012DFG31890) and Gansu Provincial Funds for Distinguished Young Scientists. This study was also supported by National Natural Science foundation of China (No. 31172335 and No. 31072143).
- Bruner DW, Gillespie GH: The family Picornaviridae. Hagan’s Infectious Disease of Domestic Animals, volume 6 1973, 1207–1028.Google Scholar
- Li D, Shang YJ, Liu ZX, Liu XT, Cai XP: Molecular relationships between type Asia 1 new strain from China and type O Panasia strains of foot-and-mouth-disease virus. Virus Genes 2007, 35: 273-279. 10.1007/s11262-006-0073-9PubMedView ArticleGoogle Scholar
- Skinner HH: Some techniques for producing and studying attenuated strains of the virus of foot and mouth disease. Bull. OIE 1960, 53: 634-650.Google Scholar
- Foot and Mouth Disease OIE Terrestrial Manual 2009, Chapter 2.1.5: 1-29.Google Scholar
- Vangrysperre W, Clercq KD: Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses. Arch Virol 1996, 141: 331-344. 10.1007/BF01718403PubMedView ArticleGoogle Scholar
- Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL: Comparative genomics of foot and mouth disease virus. J Virol 2005, 79: 6487-6504. 10.1128/JVI.79.10.6487-6504.2005PubMedPubMed CentralView ArticleGoogle Scholar
- Domingo E, Escarmis C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Nunez JI, Sobrino F: Evolution of foot-and-mouth disease virus. Virus Res 2003, 91: 47-63. 10.1016/S0168-1702(02)00259-9PubMedView ArticleGoogle Scholar
- Pereira HG: Subtyping of foot and mouth disease virus. Dev Biol Stand 1977, 35: 167-174.Google Scholar
- Ma LN, Zhang J, Chen HT, Zhou JH, Ding YZ, Liu YS: An overview on ELISA techniques for FMD. Virol J 2011, 8: 419. 10.1186/1743-422X-8-419PubMedPubMed CentralView ArticleGoogle Scholar
- Lu Z, Cao Y, Bao H, Qi S, Guo J, Shang Y, Jiang T, Zhang Q, Ma J, Liu Z, Liu X, Yin H, Xie Q: Techniques Developed in China for Foot-and-Mouth Disease Diagnosis. Transbound Emerg Dis 2008, 55: 196-199. 10.1111/j.1865-1682.2008.01027.xPubMedView ArticleGoogle Scholar
- Rémond M, Kaiser C, Lebreton F: Diagnosis and screening of foot-and mouth disease. Comp Immunol Microbiol Infect Dis 2002, 25: 309-320. 10.1016/S0147-9571(02)00028-0PubMedView ArticleGoogle Scholar
- Bao HF, Li D, Guo JH, Lu ZX, Chen YL, Liu ZX, Liu XT, Xie QG: A highly sensitive and specific multiplex RT-PCR to detect foot-and-mouth disease virus in tissue and food samples. Arch Virol 2008, 153: 205-209. 10.1007/s00705-007-1082-yPubMedView ArticleGoogle Scholar
- Ferris NP, Nordengrahn A, Hutchings GH, Reid SM, King DP, Ebert K, Paton DJ, Kristersson T, Brocchi E, Grazioli S, Merza M: Development and laboratory validation of a lateral flow device for the detection of foot-and-mouth disease virus in clinical samples. J Virol Methods 2009, 155: 10-17. 10.1016/j.jviromet.2008.09.009PubMedView ArticleGoogle Scholar
- Ferris NP, Nordengrahn A, Hutchings GH, Paton DJ, Kristersson T, Brocchi E, Grazioli S, Merza M: Development and laboratory validation of a lateral flow device for the detection of serotype SAT 2 foot-and-mouth disease viruses in clinical samples. J Virol Methods 2010, 163: 474-476. 10.1016/j.jviromet.2009.09.022PubMedView ArticleGoogle Scholar
- Brocchi E, De Simone F, Bugnetti M, Gamba D, Capucci L: Application of a monoclonal antibody based competition ELISA to the measurement of anti-FMDV antibodies in animal sera. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease: 24–25 June, 1990; Lindholm, Denmark 1990, 83-88.Google Scholar
- Crowther JR: The use of monoclonal antibodies in the molecular typing of animal viruses. Rev Sci Tech Off Int Des Epiz 1993, 12: 369-383.Google Scholar
- Ma LN, Liu YS, Ding YZ, Chen HT, Zhou JH, Liu WQ, Wang M, Zhang J: Preparation and Characterization of Neutralizing Monoclonal Antibodies Against FMDV Serotype O with Synthetic Peptide Antigen. Hybridoma 2010, 29: 409-412. 10.1089/hyb.2010.0031PubMedView ArticleGoogle Scholar
- Alexandersen , Zhang Z, Donaldson AI, Garland AJ: The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol 2003, 129: 1-36. 10.1016/S0021-9975(03)00041-0PubMedView ArticleGoogle Scholar
- Reid SM, Ferris NP, Hutchings GH, Samuel AR, Knowles NJ: Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction. J Virol Methods 2000, 89: 167-176. 10.1016/S0166-0934(00)00213-5PubMedView ArticleGoogle Scholar
- Reid SM, Ferris NP, Hutchings GH, Zhang Z, Belsham GJ, Alexandersen S: Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J Virol Methods 2001, 105: 67-80.View ArticleGoogle Scholar
- Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T: Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000, 28: e63. 10.1093/nar/28.12.e63PubMedPubMed CentralView ArticleGoogle Scholar
- Chen HT, Zhang J, Ma YP, Ma LN, Ding YZ, Liu XT, Cai XP, Ma LQ, Zhang YG, Liu YS: Reverse transcription loop-mediated isothermal amplification for the rapid detection of infectious bronchitis virus in infected chicken tissues. Mol Cell Probes 2010, 24: 104-106. 10.1016/j.mcp.2009.10.001PubMedView ArticleGoogle Scholar
- Chen HT, Zhang J, Sun DH, Ma LN, Liu XT, Cai XP, Liu YS: Development of reverse transcription loop-mediated isothermal amplification for rapid detection of H9 avian influenza virus. J Virol Methods 2008, 151: 200-203. 10.1016/j.jviromet.2008.05.009PubMedView ArticleGoogle Scholar
- Chen HT, Zhang J, Sun DH, Ma LN, Liu XT, Quan K, Liu YS: Reverse transcription loop-mediated isothermal amplification for the detection of highly pathogenic porcine reproductive and respiratory syndrome virus. J Virol Methods 2008,153(2):266-268. 10.1016/j.jviromet.2008.07.006PubMedView ArticleGoogle Scholar
- Iwamoto T, Sonobe T, Hayashi K: Loop-Mediated Isothermal Amplification for Direct Detection of Mycobacterium tuberculosis Complex, M. avium, and M. intracellulare in Sputum Samples. J Clin Microbiol 2003, 41: 2616-2622. 10.1128/JCM.41.6.2616-2622.2003PubMedPubMed CentralView ArticleGoogle Scholar
- Chen HT, Zhang J, Liu YS, Liu XT: Detection of foot-and-mouth disease virus rna by reverse transcription loop-mediated isothermal amplification. Virol J 2011, 8: 510. 10.1186/1743-422X-8-510PubMedPubMed CentralView ArticleGoogle Scholar
- Mori Y, Nagamine K, Tomita N, Notomi T: Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun 2001, 289: 150-154. 10.1006/bbrc.2001.5921PubMedView ArticleGoogle Scholar
- Nam JM, Thaxton CS, Mirkin CA: Nanoparticle-based bio-barcodes for the ultrasensitive detection of proteins. Science 1884, 2003: 301.Google Scholar
- Ding YZ, Liu YS, Zhou JH, Chen HT, Wei G, Ma LN, Zhang J: A highly sensitive detection for foot-and-mouth disease virus by gold nanopariticle improved immuno-PCR. Virol J 2011, 8: 148. 10.1186/1743-422X-8-148PubMedPubMed CentralView ArticleGoogle Scholar
- Wang XS, Sun Y, Jing S, Ma XM, Zeng Y: Combining gold nanoparticles with real-time immuno-PCR for analysis of HIV p24 antigens. Bioinformatics and Biomedical Engineering. The 1st International Conference on ICBBE 2007, 1198.Google Scholar
- Chen LY, Wei HP, Guo YC, Cui ZQ, Zhang ZP, Zhang XE: Gold nanoparticle enhanced immuno-PCR for ultrasensitive detection of Hantaan virus nucleocapsid protein. J Immunol Meth 2009, 346: 64-70. 10.1016/j.jim.2009.05.007View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.